APA (7th ed.) Citation

Stahl, M., Röhmel, J. F., Wielpütz, M. O., & Mall, M. A. (2025). Reply to Martin and Grasemann: Is there a role for lumacaftor/ivacaftor in young children with cystic fibrosis? Annals of the American Thoracic Society, 22(3), . https://doi.org/10.1513/AnnalsATS.202411-1237LE

Chicago Style (17th ed.) Citation

Stahl, Mirjam, Jobst Fridolin Röhmel, Mark Oliver Wielpütz, and Marcus A. Mall. "Reply to Martin and Grasemann: Is There a Role for Lumacaftor/ivacaftor in Young Children with Cystic Fibrosis?" Annals of the American Thoracic Society 22, no. 3 (2025). https://doi.org/10.1513/AnnalsATS.202411-1237LE.

MLA (9th ed.) Citation

Stahl, Mirjam, et al. "Reply to Martin and Grasemann: Is There a Role for Lumacaftor/ivacaftor in Young Children with Cystic Fibrosis?" Annals of the American Thoracic Society, vol. 22, no. 3, 2025, https://doi.org/10.1513/AnnalsATS.202411-1237LE.